[ORGANIZATION]
BioMarin Pharmaceutical
Featured in 2 tracked stories · first seen
Situations
AstraZeneca stock performance and earnings
3 clusters · 5 sources · last updated
Latest: AstraZeneca shares rise following positive quarterly results
AstraZeneca shares initially saw a slight increase of 0.2% to 118.90 GBP following reports of a 5.84% year-over-year increase in quarterly revenue. The company also noted the expansion of its breast cancer drug, Enhertu,
Also covered in
-
GC Biopharma and Hanmi Pharm license Fabry disease therapy to BioMarin
[BUSINESS] · 11 sources ·